Annual variation in attentional response after methylphenidate treatment

Eur Child Adolesc Psychiatry. 2020 Sep;29(9):1231-1236. doi: 10.1007/s00787-019-01434-1. Epub 2019 Nov 20.

Abstract

Prevalence rates of attention-deficit/hyperactivity disorder (ADHD) differ with geographical areas varying in sunlight intensity. Sun- or daylight reaching the retina establishes entrainment of the circadian clock to daylight. Changes herein, hence, alterations in clock alignment, could be reflected indirectly in inattention via sleep duration. We here studied (1) annual variation in inattention at treatment initiation; (2) annual variation in response to ADHD treatment [methylphenidate (MPH)] by day of treatment initiation; and (3) dose dependence. We predicted least baseline inattention during a period of high sunlight intensity implying more room for improvement (i.e., a better treatment response) when sunlight intensity is low. These hypotheses were not confirmed. High-dose treated patients, however, had significantly better attention after treatment than low-dosed treated patients, only when treated in the period from winter to summer solstice. Change in solar irradiance (SI) during low-dosed treatment period was negatively related to attentional improvement. The above described findings were primarily found in inattention ratings and replicated in omission errors on a continuous performance task. Daylight and inattention have been proposed to be related via mediation of the circadian system. One mechanism of MPH may be to enhance sensitivity to the diurnal entrainment to sunlight and the question can be raised whether appropriate lighting could potentiate the effects of stimulants.

Keywords: ADHD; Annual variation; Inattention; Methylphenidate; Sunlight.

MeSH terms

  • Adolescent
  • Attention Deficit Disorder with Hyperactivity / etiology*
  • Central Nervous System Stimulants / adverse effects*
  • Central Nervous System Stimulants / pharmacology
  • Central Nervous System Stimulants / therapeutic use
  • Child
  • Female
  • Humans
  • Male
  • Methylphenidate / adverse effects*
  • Methylphenidate / pharmacology
  • Methylphenidate / therapeutic use
  • Prevalence
  • Sunlight / adverse effects*
  • Time Factors
  • Treatment Outcome

Substances

  • Central Nervous System Stimulants
  • Methylphenidate